TrialArthritis research & therapy2024

Effect of ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study.

Panagiota Xanthouli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.